A Single-Center, Open-Label, One-Sequence, 2-Period, Within-Subject Study in 2 Cohorts to Investigate the Effect of Multiple Doses of Itraconazole (Cohort 1) and Fluoxetine (Cohort 2) on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects

Trial Profile

A Single-Center, Open-Label, One-Sequence, 2-Period, Within-Subject Study in 2 Cohorts to Investigate the Effect of Multiple Doses of Itraconazole (Cohort 1) and Fluoxetine (Cohort 2) on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs RG 7314 (Primary) ; Fluoxetine; Itraconazole
  • Indications Psychotic disorders
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 24 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov record.
    • 18 Nov 2013 Planned End Date changed from 1 Nov 2013 to 1 Dec 2013as reported by ClinicalTrials.gov.
    • 13 Nov 2013 Planned end date changed from 1 Dec 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top